Pearl Therapeutics Receives Award for Innovative Co-Suspension Technology

Published: Mar 14, 2013

REDWOOD CITY, CALIF, March 14, 2013 (GLOBE NEWSWIRE) -- Pearl Therapeutics Inc. today announced their receipt of the 2013 Drug Delivery Partnerships™ (DDP) Innovation Award for the Company's novel co-suspension formulation technology. These awards honor companies that have demonstrated exemplary leadership and scientific/technological innovation in the field of drug delivery and development. The award to Pearl was announced at the 4th annual Drug Delivery Partnership conference held by Institute for International Research.

Back to news